KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Cash & Equivalents (2016 - 2025)

Opko Health's Cash & Equivalents history spans 16 years, with the latest figure at $369.1 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 14.55% year-over-year to $369.1 million; the TTM value through Dec 2025 reached $369.1 million, down 14.55%, while the annual FY2025 figure was $369.1 million, 14.55% down from the prior year.
  • Cash & Equivalents reached $369.1 million in Q4 2025 per OPK's latest filing, down from $415.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $436.0 million in Q1 2025 to a low of $40.6 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $199.3 million, with a median of $143.6 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: crashed 62.47% in 2024, then soared 569.65% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $134.7 million in 2021, then grew by 13.72% to $153.2 million in 2022, then plummeted by 37.41% to $95.9 million in 2023, then surged by 350.49% to $431.9 million in 2024, then fell by 14.55% to $369.1 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Cash & Equivalents are $369.1 million (Q4 2025), $415.2 million (Q3 2025), and $271.7 million (Q2 2025).